fbpx

Clinical Trial Launched to Test New Drug for AMD and DME

Fighting Blindness Canada funded researcher Dr. Sachdev Sidhu (University of Waterloo) has developed a novel antibody therapy that will now be tested in a Phase 1/2 human clinical trial.

An intact blood-retinal barrier is important for proper retinal function. This is disrupted in eye diseases such as wet age-related macular degeneration (AMD) and diabetic macular edema (DME) where uncontrolled blood vessel growth disrupts the barrier, allowing fluid to leak into the eye. If untreated, this can lead to retinal damage and vision loss.

DR. SIDHU’S RESEARCH

Currently, the main treatment for AMD and DME is anti-VEGF, which reduces blood vessel growth. However, anti-VEGF treatments do not fix damage to the blood-retinal barrier.

Dr. Sidhu has developed a new antibody treatment (EYE103) which has the potential to restore the blood retinal barrier and help improve vision for those with AMD or DME.

The clinical trial will involve approximately 90 patients and will test if EYE103 is safe.

Featured Posts

Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read more

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read more

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read more

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read more
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read More

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read More

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read More

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read More
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read more

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read more

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read more

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read more
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read more

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read more

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read more

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read more